Dr Nick Broughton

Asthma and Lung UK and Sanofi are committed to supporting healthcare professionals in providing the highest quality care for COPD patients. Through education, collaboration, and advocacy, we aim to equip clinicians with the tools they need to optimize patient outcomes. Our ambition is for people to #BreatheEqual, to see improvements in the recognition, diagnosis and quality of care for those suffering with respiratory conditions, regardless of location and socio-economic status. See our mission statement here: https://lnkd.in/eVBAsVpc Asthma + Lung UK (asthmaandlung.org.uk)

28

Join GatewayC for their free webinar on endometrial cancer. This session will provide essential updates to support earlier cancer diagnosis in primary care and effective patient management. With around 9,800 new cases diagnosed annually in the UK, endometrial cancer is the fourth most common cancer in women. Understanding risk factors, recognising red flag symptoms like postmenopausal bleeding, and knowing when and how to investigate are crucial for early detection and patient outcomes. https://lnkd.in/ejRctEcw #PrimaryCare

5

Navigating a rare cancer diagnosis can be overwhelming. In this short video, we break down some key steps to help you understand and navigate the treatment options and support available in the UK, helping you find clarity and confidence on your journey. Watch to learn more. #cancercare #cancertreatments #NHS

3

We are proud to be sponsoring this upcoming Market Access Masterclass on September 26th, hosted by the The Pharmaceutical Managers Institute. With an impressive lineup of speakers, including Dr Lesley Tilson, Orla Maguire, and Dr Joy Leahy from the NCPE, we are looking forward to gaining valuable insights into the latest updates on the NCPE Budget Impact Model and best practices for budget impact analysis. We hope to see many of you there for what promises to be a highly informative session! Booking details below 👇 #MarketAccess #Healthcare #BudgetImpactAnalysis #HTA #SalutemInsights

6

1 in 8 men will get prostate cancer. If you’re over 50, or you’re black, or your dad or brother had it, you’re at even higher risk. Answer three quick questions to check your risk on Prostate Cancer UK's risk checker. https://lnkd.in/dqtPVMK #theprostateproject #prostatecancerawareness Prostate Cancer UK

10

Interesting case report demonstrating the clinical improvements and safety of #deprescribing a strong #anticholinergic drug doxepin: https://buff.ly/3QEUYJA Carina Lundby Barbara Farrell British Pharmacological Society Great use of the ACBcalc online calculator! 💡 https://buff.ly/3QZXiuX #geriatrics #medicine #pharmacy #polypharmacy #elderly

55

Join us to explore how we can collectively build a more trustworthy and impactful #health system and elevate the UK #LifeSciences sector. Recent studies in the UK have highlighted public sentiments when it comes to #vaccines and #clinicalresearch. Understanding public concerns about vaccines is crucial, as effective communication and trust-building can help individuals make informed health decisions. Clinical research plays a crucial role in providing #evidence on vaccine safety and efficacy, which reinforces #public #confidence. To enhance vaccine uptake and address hesitancy, collaboration between health authorities and researchers is vital. At this summit, we will address these critical issues through expert panels and insightful discussions aimed at building a more #trustworthy and #effective health system. 🎟 Secure your spot: https://lnkd.in/dFjdpjYB White City Innovation District Hammersmith & Fulham Council Imperial College Chemistry Society Imperial Enterprise Imperial College Bioengineering Society I-HUB Scale Space I-X UKTN Blenheim Chalcot Imperial College Advanced Hackspace Imperial Enterprise Lab Mary Ryan Oscar Ces Startup Grind Impact Hub Network Huckletree Royce at Imperial #JawdropFireside24 #HealthOutcomes #LifeSciences #TrustInHealthcare #UKHealth #VaccineHesitancy

4

🎙️ Tune into Let’s Talk About SACT, the Cancer Pharmacy Podcast presented by The British Oncology Pharmacy Association. Dedicated to advancing excellence in the pharmaceutical care of patients with cancer, via monthly educational releases. Don’t miss out on the latest insights and innovations. 🔗 Listen here: https://lnkd.in/eVhuAD5a #MedLearn24 #NHSCancer #CancerUK #Oncology #NHS #SACT

1

📢 Have you signed up for tomorrow's 60-minute masterclass, Generics, Branded Generics and Biosimilars: NHS Update? Key Learning Objectives: 💊 Understand the landscape of generics, branded generics and biosimilars in the NHS 💊 Gain insight into the clinical and economic considerations for the use of generics, branded generics, and biosimilars 💊 Learn about the latest developments in the research and development of generic and biosimilar medicines 💊 Explore the implications of the evolving NHS landscape on the pharma industry Can't make it tomorrow? Register and we'll send you a link to the recording so you can watch it on demand in your own time. #Pharma2025 #LifeSciences #LSAA #PatientOutcomes #HealthcareInnovation #VPAG #Generics #BrandedGenerics #Biosimilars #NHS #PharmaTrends #HealthPolicy #ClinicalEconomics #PharmaceuticalResearch #IndustryLeaders #HealthcareMasterclass #PharmaUpdates #HealthcareBestPractices LSAA Members register here: https://lnkd.in/eRAecU7E 🎙️Connect with us! Speakers: Clara Carter Lee Cornell Peter Kelly Kristine Oberte William Sanders Host: Ian Chamberlain To see our other masterclasses, go to our website: https://lnkd.in/eVJWfGih

2

ICYMI: The Cell and Gene Therapy Catapult (CGT) has released its 2024 Annual Review 🦠🔬. This report highlights significant milestones made by the CGT Catapult and the UK’s advanced therapy medicinal products (ATMP) industry. Key achievements from the past year include: ➡️ 79 companies collaborated with on ATMP innovation (56% of which are UK SMEs) ➡️ £656m in financing raised by their UK collaborators (including £453m by its collaborators in Stevenage) ➡️ 11 companies supported that are conducting clinical trials As part of the Innovate UK Catapult Network, the CGT Catapult plays a crucial role in driving the growth of next-generation therapies that can transform patient care and contribute to national economic growth. Read the report here: https://lnkd.in/eJetPtsy...

12

NEWS | CPI joins the Pathways to Antimicrobial Clinical Efficiency (PACE) Delivery Partner Network. PACE was founded in 2023 by LifeArc, Medicines Discovery Catapult, and Innovate UK as a £30 million 5-year programme with a new approach to tackling antimicrobial resistance (AMR). By leveraging our expertise and capabilities in AMR product development across antibodies, recombinant proteins, phage and microbiome therapies, CPI will help partners joining the PACE Network to tackle manufacturing and regulatory challenges and bring novel AMR products to market. Through strategic partnerships focused on advanced R&D, facilitated by networks such as PACE-DPN, we can make a significant impact in the fight against AMR and secure a healthier future. Find out more ➡️ https://lnkd.in/ebRDF5gd Philip Probert Suzanne Robb Jade McKendrick Alix Mackay Jonathan Jones LifeArc Medicines Discovery Catapult Innovate UK #AntimicrobialResistance | #AMR | #MedicinesManufacturing #LetsInnovateTogether | #Innovation | #Pharma

61

1 Comment